Pancreatic Cancer Group: Introduce yourself and connect with others
Welcome to the Pancreatic Cancer group on Mayo Clinic Connect.
This is a welcoming, safe place where you can meet people living with pancreatic cancer or caring for someone with pancreatic cancer. Let’s learn from each other and share stories about living well with cancer, coping with the challenges and offering tips.
I’m Colleen, and I’m the moderator of this group, and Community Director of Connect. Chances are you’ll to be greeted by fellow members and volunteer patient Mentors, when you post to this group. Learn more about Moderators and Volunteer Mentors on Connect.
We look forward to welcoming you and introducing you to other members. Feel free to browse the topics or start a new one.
Pull up a chair. Let's start with introductions.
When were you diagnosed with pancreatic cancer? What treatments have you had? How are you doing?
Interested in more discussions like this? Go to the Pancreatic Cancer Support Group.
Thank you. Taking this to my oncology team. Brenda
When I was on standard Folfirinox from 2012-2014, I only required one administration of Neulasta to raise my WBC count. The 14 day Administration cycle of FFX was never impacted. My platelet counts fluctuated but never low enough to postpone chemo.
Normal rapidly dividing cells although affected by chemo are not impacted to the same degree as malignant cells. My reducing dosage and administering more frequently, the healthy rapidly dividing cell tropes are more robust while the malignant rapidly dividing cells are still sensitive to the toxicity of the drug.
It is interesting that using an antibiotic is more like the metronomic approach.You don’t get blasted with a massive bolus of an antibiotic. They use the Mean Inhibitory Concentration approach where you get a concentration of the minimum amount plus a little extra to be on the safe side to be bacterialcidal against the bacterial strain and at certain time points over the course of 1-2 weeks. Metronomic dosing is similar in this respect-enough of a concentration to kill malignant cells with less impact on healthy cells and easier on the patient.
This is wonderful and so glad for you. did you experience issues with platelets and/or Neutrophils? Do you think the metronomic dosing helps with these issues. I had no major side effects except the cell counts. 5FU gave me no issues either. Thanks for your comments.
At initial diagnosis using CT and brush cytology with an EUS, it was believed I was stage IIb. An ERCP followed to insert a stent. This all occurred over a span of three days ending on a Friday. Monday morning I was opened in the OR and it was observed the tumor (4cm x3cmx3cm) was involved with the portal vein. Pathological examination showed invasion of malignant cells through the vascular wall. One week after the Whipple, another CT was done and this time the radiologist noted in the report suspicious areas were noted in the liver. Subsequent scans repeated that finding and after three months on Gemzar, there were six sizable tumors in the liver and one was biopsied to confirm metastatic disease.
It wasn’t a case that metastatic disease first developed one week after the Whipple. It was already there but too small to be detected by conventional methods imaging methods in 2012. The resolution of a CT scan then was 4mm best.In 2022, Siemens and GE scanners can resolve down to 1.3mm. Oncologists and surgeons familiar with my case concur metastatic spread was already present at the time of the initial CT scan on 6/12/2012. Fifteen days later when the second CT was done ( 1 week post Whipple), the aggressive nature of the tumor type (PACC) had grown enough to be picked up by the scanner and noted by the radiologist. A review of the initial scan did not show it.
Questions I have is whether having the Whipple procedure reduced the tumor burden to help my immune system in conjunction with aggressive chemotherapy and a PARP inhibitor contribute to reaching NED or if surgical resection had not been done and just treated with SOC, would I have achieved NED and have a fully intact and functioning pancreas? I personally know two woman that were stage IV and non-resectable, treated aggressively-one was with Folfirinox. The other woman was treated with multiple drugs 24 years ago when Folfirinox did not yet exist. Both are long-term NED survivors with functioning pancreases.
Remarkable and so happy for you. Thanks for providing so much detail. Was your original cancer contained to the pancreas or was there any spread at that time?
We're in the very beginning of this so don't know much about it yet, but we're at Mayo-Rochester and so far it looks like they have caught it early by paying attention to an episode of back pain he had in April.
We should be "staged" by the end of this week but they have just installed a port for chemo, and will do some of that before they proceed with surgery. New approach of "chemo first" seems promising - even if surgery is still needed, results have been better than the past approach of "surgery first."
But just starting on our path.
We are in a similar situation but my husband has had the Whipple procedure and is recovering. What surprised me most is the exhaustion he suffers daily. Are you satisfied with the’care team’ you have?
Coming from a background in cancer, immunology and cancer stem cell research, a ten year survivor of stage IV pancreatic cancer and serving as a mentor to many pancreatic cancer patients, I’ve been asked a number of times why 12 cycles is the “magic” number.
As a researcher, I expected there was either an animal or human study done. After an extensive search, I asked three of the most experienced oncologists that played a role in the Folfirinox being FDA approved or the clinical studies showing superiority over other treatments. The three oncologists with the most experience with Folfirinox are William Isacoff (now retired from UCLA), Daniel VonHoff (retired from Honor Health in Phoenix) and Thierry Conroy in Nancy, France who is still an active clinician. No one could give me a clear answer and it seemed to be based on an “average” patient being able to handle that much without significant peripheral neuropathy and provide therapeutic value in treating systemic disease.
As a researcher with an understanding of cancer biology and the concepts of NED and MRD, my goal was in surviving the disease first. With stage IV disease and the desire to survive-buying extra time was not an option. It was do or die so I did. And not only did I do 12 cycles of the original formulation that is 20% higher than today’s (m)Folfirinox, I did 24 cycles over a two year period interspersed with 5-FU+Leucovorin as resting cycles. It was done in groups of six. Oncologists like to have their patients try to make it to eight cycles as it is felt more benefit is gained if that point can be reached. For patients having a hard time dealing with standard treatment, there is a method known as metronomic dosing. It has been around for more than 20 years and Dr. William Isacoff is a proponent. It can be hard to find oncologists who use the technique but they are around. With metronomic dosing, small amounts of the chemo are used but given more frequently. While still toxic to malignant cells, the effects on healthy cells are minimized. Here are some links with more detail of the technique-
Metronomic Dosing
LetsWinPC.org ran a feature story about metronomic dosing a few years ago and a search will provide the link. The National Library of Medicine at the NIH is the source of two studies on the technique. Because I am posting for the first time, the site will not permit me to provide the links.
Chemo can be grueling but I was determined to have some good come out of a bad situation. I had to toughen myself emotionally, mentally and physically to get through it. I refused to let the cancer define me and I went about my daily life as normal as possible.
I had an excellent response to the treatment and during that time I was genetically tested leading to uncovering a mutation that was driving my cancer. After completing the “gold standard” chemo, I entered the clinical trial. Years later members of my care team shared something they dared not say when I was under treatment nor did I ask or want to know-how long did they expect me to survive at the point I started chemo. I was told not more than one year. Ten years later I give some of the credit to sticking it out on Folfirinox to reduce the tumor burden and then using the clinical trial drug as long-term maintenance therapy that I have been taking for the last 7 years and 8 months. I have been N.E.D. since April 2016.
Has anyone heard of or tried Enterade? The chemo drink?
Thank you and you are correct!🙏